Yardley, PA, United States of America

Xiaoni Liu

USPTO Granted Patents = 3 


Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Princeton, NJ (US) (2019)
  • Yardley, PA (US) (2022 - 2024)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Xiaoni Liu in Autoimmune Disease Treatment

Introduction

Xiaoni Liu is a notable inventor based in Yardley, PA (US), recognized for his contributions to the field of autoimmune disease treatment. He holds 3 patents that focus on innovative methods for addressing systemic lupus erythematosus, a challenging autoimmune condition.

Latest Patents

Among his latest patents, Liu has developed methods of treating systemic lupus erythematosus using a domain antibody directed against CD28. These methods provide a novel approach to treating autoimmune diseases by utilizing domain antibodies that specifically bind to human CD28. The administration cycle may include one dose of the domain antibody, which has been shown to reduce symptoms of systemic lupus erythematosus compared to placebo.

Career Highlights

Liu's career is marked by his work at Bristol-Myers Squibb Company, where he has been instrumental in advancing research and development in the field of immunology. His innovative approaches have contributed significantly to the understanding and treatment of autoimmune diseases.

Collaborations

Liu collaborates with esteemed colleagues such as Marek Honczarenko and Rong Shi, enhancing the research efforts within his team and contributing to the advancement of medical science.

Conclusion

Xiaoni Liu's work exemplifies the impact of innovation in the treatment of autoimmune diseases, particularly systemic lupus erythematosus. His patents and collaborations continue to pave the way for new therapeutic strategies that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…